NASDAQ:BPTH
Bio-Path Holdings Stock News
$2.49
-0.195 (-7.26%)
At Close: Apr 24, 2024
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
11:16am, Friday, 19'th Apr 2024
Bio-Path (BPTH) gains 30% on encouraging developmental updates from the early-stage study of its investigational candidate, BP1002, to treat acute myeloid leukemia patients.
Why Is Bio-Path (BPTH) Stock Up 89% Today?
10:28am, Thursday, 18'th Apr 2024
Bio-Path (NASDAQ: BPTH ) stock is rising higher on Thursday after the oncology company announced an update on its Phase 1/1b clinical trial of BP1002. This clinical trial is focusing on the use of BP
Bio-Path Holdings shares sink 6% after deal for at-the-market offering
07:14pm, Thursday, 04'th Apr 2024
Shares of Bio-Path Holdings BPTH, -0.06% fell late Thursday after the company said it had reached a deal for an at-the-market share offering.
Bio-Path Holdings Inc. (BPTH) Q4 2023 Earnings Call Transcript
10:28am, Friday, 08'th Mar 2024
Bio-Path Holdings Inc. (NASDAQ:BPTH ) Q4 2023 Results Conference Call March 8, 2024 8:30 AM ET Company Participants Will O'Connor - Stern Investor Relations Peter Nielsen - CEO and CFO Anthony Price -
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024
07:00am, Friday, 01'st Mar 2024
HOUSTON, March 01, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a p
Bio-Path Holdings, Inc. (BPTH) Q3 2023 Earnings Call Transcript
05:28pm, Wednesday, 15'th Nov 2023
Bio-Path Holdings, Inc. (NASDAQ:BPTH ) Q3 2023 Earnings Call Transcript November 15, 2023 8:30 AM ET Company Participants Will O'Connor - IR, Stern IR Peter Nielsen - President and CEO Anthony Price -
Bio-Path Holdings to Announce Third Quarter 2023 Financial Results on November 15, 2023
07:00am, Wednesday, 08'th Nov 2023
HOUSTON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a po
Bio-Path Holdings to Present at H.C. Wainwright 25th Annual Global Investment Conference
04:01pm, Friday, 08'th Sep 2023
HOUSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develo
Bio-Path Holdings, Inc. (BPTH) Q2 2023 Earnings Call Transcript
01:44pm, Tuesday, 15'th Aug 2023
Bio-Path Holdings, Inc. (NASDAQ:BPTH ) Q2 2023 Results Conference Call August 15, 2023 8:30 AM ET Company Participants Will O'Connor - Investor Relations, Stern IR Peter Nielsen - President and Chief
Bio-Path Holdings to Announce Second Quarter 2023 Financial Results on August 15, 2023
07:00am, Tuesday, 08'th Aug 2023
HOUSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a
Why Is Bio-Path (BPTH) Stock Down 12% Today?
09:17am, Monday, 26'th Jun 2023
Bio-Path (NASDAQ: BPTH ) stock is sliding lower on Monday after the company announced a proposed public share offering. Bio-Path has yet to reveal the major details of its planned public offering.
Bio-Path Holdings, Inc. (BPTH) Q1 2023 Earnings Call Transcript
10:06am, Friday, 12'th May 2023
Bio-Path Holdings, Inc. (NASDAQ:BPTH ) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ET Company Participants Will O'Connor - Investor Relations, Stern IR Peter Nielsen - President and Chief Ex
Bio-Path Holdings to Announce First Quarter 2023 Financial Results on May 12, 2023
07:00am, Friday, 05'th May 2023
HOUSTON, May 05, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a por
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2022 Financial Results on March 31, 2023
04:01pm, Friday, 24'th Mar 2023
HOUSTON, March 24, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a p
Bio-Path Holdings Inc. (BPTH) Q3 2022 Earnings Call Transcript
11:20am, Tuesday, 15'th Nov 2022
Bio-Path Holdings Inc. (NASDAQ:BPTH ) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants Will O'Connor - Stern Investor Relations Peter Nielsen - CEO and CFO Anthony Pr
